When is off-label off-road?

Ann Oncol. 2019 Oct 1;30(10):1536-1538. doi: 10.1093/annonc/mdz445.

Authors

E G E de Vries¹, N I Cherny², E E Voest³

Affiliations

¹ Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: e.g.e.de.vries@umcg.nl.
² Department of Medical Oncology, Cancer Pain and Palliative Medicine Service, Shaare Zedek Medical Center, Jerusalem, Israel.
³ Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Amsterdam, The Netherlands.

No abstract available

Publication types

Editorial

MeSH terms

Drug Approval / legislation & jurisprudence*
Drugs, Investigational / standards*
Drugs, Investigational / therapeutic use
Humans
Off-Label Use / standards*
Off-Label Use / statistics & numerical data*
Practice Guidelines as Topic / standards*

Substances

Drugs, Investigational